23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Posted in23andMe Bankruptcies Bonta, Rob (1972- ) DNA (Deoxyribonucleic Acid) Genetics and Heredity Mergers, Acquisitions and Divestitures Privacy Regeneron Pharmaceuticals Inc Tarrytown (NY) Wojcicki, Anne Yancopoulos, George D

23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
SPAC Deals Are Back, This Time With a Trump Bump
Posted inCantor Fitzgerald LP Initial Public Offerings Lutnick, Howard W Mergers, Acquisitions and Divestitures Nunes, Devin G Securities and Exchange Commission Special Purpose Acquisition Companies (SPAC) Stocks and Bonds Trump Media & Technology Group Trump, Donald J

SPAC Deals Are Back, This Time With a Trump Bump

President Trump’s associates and crypto entrepreneurs are rushing back to the market for the once-hot, but mostly troubled, investment vehicles called special purpose acquisition companies.